Vasopressor Ppt and Latest 50 Published articles

Vasopressor: causing an increase in blood pressure by constricting the arteries;  a substance that has such an effect.

Cardiovascular  management of septic  shock
Cardiovascular%20management%20of%20septic%20shock.ppt

Vasoactive  Agents in Emergency Care
by Susan  P. Torrey, M.D., FACEP
http://vietnamem.org/ubr_uploads/MD_2012/EN_Vasopressors.ppt

Updates in Haemodynamics Support
by Dr.  OY Tam, Dr. LL Chang
ICU-Surgical%20Inter-departmental%20Grand%20Round%20v2.ppt

Inotropes & Vasopressors
by Dr  Cathy Armstrong
Inotropesvasopressors.ppt

Pressors
by Scott  Forman, D.O.
pcommed.com/Pressors.ppt

Vasoactive  drugs in the intensive  care unit
by Holmes, Cheryl L
vasoactive drugs.ppt

Steroids  in Vasopressor-Dependent Sepsis
by Melissa  Hynes, MD
SteroidSepsis.ppt

Overview  and Use of Pressors
Emphasis on Cardiogenic, Neurogenic, and Septic Shock
by Alexander  R. Raines, M.D
Overview%20and%20Use%20of%20Pressors%20%20%20%20Raines.ppt

Arginine  Vasopressin in Advanced  Vasodilatory Shock
http://www.anesthesia21.com/board/data/DeptNews/AVP.ppt

Management of Septic Shock
http://sparmy.com/Quake%20stuff/hypertension/SEPSISrevised.PPT

Latest 50 Publications

Read more...

Current Clinical Trials on Vitiligo / Switra in Ayurveda / Venpadai in Siddha

Current Clinical Trials on Vitiligo (Switra in Ayurveda, Venpadai in Siddha)

1. HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home
2. Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
3. Vitiligo Skin Transplantation
4. Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents
5. Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
6. Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo
7. Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
8. Clinical Trial of Simvastatin to Treat Generalized Vitiligo
9. Botulinum Toxin Treatment for Localized Vitiligo
10. Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
11. Punchgrafting Techniques for Vitiligo
12. Efficacy and Safety of ACH24 in the Treatment of Vitiligo
13. Treatment of Vitiligo With Low-energy Visible Light Laser
14. Narrowband UVB Treatment in Patients With Vitiligo
15. Topical Bimatoprost Solution 0.03%in Stable Vitiligo
16. Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
17. Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment
18. Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo
19. Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
20. Questionnaire and Laboratory Data on Vitiligo Vulgaris
21. Emervel Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds
22. Safety Study of Cosmetic Tissue Augmentation in People of Color
23. Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma
24. Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
25. A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.
26. Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
27. Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VI

Read more...

100 Current clinical trial details on rheumatoid arthritis

100 Current clinical trial details on rheumatoid arthritis
Click on title to view details.

1. A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece
2. A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate
3. A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
4. A Pilot Study of Potassium Supplementation for Adult Patients With Rheumatoid Arthritis
5. A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
6. A Study Comparing CRx-102 Plus Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in Rheumatoid Arthritis
7. A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis
8. A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis
9. A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
10. A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis
11. A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
12. A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
13. A Study of the Safety of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
14. A Study on the Prevalence of the Anti-MCV Anti-body in an Irish Rheumatoid Arthritis (RA) Population and the Impact of Biomarker Status on the Management of Irish Patients With Early RA
15. A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
16. A Trial to Evaluate the Safety and Tolerability of MT203 in Patients With Mild to Moderate Rheumatoid Arthritis
17. Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
18. Assessment of Body Image in Patients With Rheumatoid Arthritis
19. Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab
20. Atherosclerosis in Rheumatoid Arthritis
21. Clinically Important Changes in Rheumatoid Arthritis
22. Cognitive Behavioral Therapy Treatments for Adults With Rheumatoid Arthritis (The SARA Study)
23. Coping Skills Training for Early Rheumatoid Arthritis
24. Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)
25. Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis
26. Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis
27. Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)
28.  Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.
29. Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice
30. Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drug (DMARD)-Naïve Adults With Early Active Rheumatoid Arthritis
31. Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drug (DMARD)-Naïve Adults With Early Active Rheumatoid Arthritis
32. Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis
33. Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients
34. Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis
35. Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects
36. Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
37. Genetics of Rheumatoid Arthritis
38. Health Outcomes in Rheumatoid Arthritis
39. Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
40. Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis
41. Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis
42. Inflammation and Insulin Resistance in Rheumatoid Arthritis
43. Infliximab for the Treatment of Early Rheumatoid Arthritis
44. Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
45. Interest of a Standardized Monitoring of Rheumatoid Arthritis: The COMEDRA Trial
46. Iyengar Yoga for Young People With Rheumatoid Arthritis
47. Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid Arthritis
48. Lung Disease Associated With Rheumatoid Arthritis
49. Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)
50. Meditation-Based Stress Reduction in Rheumatoid Arthritis
51. Moderate Rheumatoid Arthritis (RA) With Enbrel
52. Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs
53. Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis
54. Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept
55. Orally Active, Small Molecule Inhibitor of MEK1 and MEK2 in Patients With Active Rheumatoid Arthritis
56. Patient Rheumatoid Arthritis Social Support Study
57. Phase II Study Evaluating the Safety and Efficacy of GSK315234 in Patients With Rheumatoid Arthritis
58. Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls
59. Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis Patients
60. PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
61. Relaxation Response Training for the Treatment of Rheumatoid Arthritis
62. Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy
63. Rheumatoid Arthritis Disease Activity Monitor
64. Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
65. Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
66. Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
67. Rosuvastatin in Rheumatoid Arthritis (RORA)
68. Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis
69.  Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis
70.  Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)
71. Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis
72. Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis
73. Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
74. Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate
75. Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)
76. Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)
77. Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis
78. Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept
79. Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
80. Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
81. Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg
82. Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
83. Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis
84. Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
85. Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders
86. Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
87. Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
88. Targeting Synovitis in Early Rheumatoid Arthritis
89. The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment (CARAT)
90. The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary Study
91. The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept
92. The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis
93. Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey
94. TIV and High Dose TIV in Subjects With Rheumatoid Arthritis
95. Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine
96. Treatment of Hypovitaminosis D in Rheumatoid Arthritis
97. Treatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis
98. Ultrasonography as a Biomarker in Early Rheumatoid Arthritis
99. Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
100. Zostavax in Rheumatoid Arthritis

Read more...